Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.51 | 8e-66 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.43 | 6e-40 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.42 | 4e-37 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.34 | 5e-25 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.33 | 8e-23 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.42 | 7e-22 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-21 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.43 | 1e-19 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-19 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-18 |